Precision oncology research program for solid tumors
Part of Cancer clinical trials.
This research program studies solid tumors to find better treatments. It collects health data to help develop personalized cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (like lung, colon, or breast cancer), but not blood cancer.
- You are well enough to walk and take care of yourself (ECOG score 0-2).
- You agree to share your health information with the research team and partners.
- You sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects evidence on personalized (“targeted”) cancer treatments for adults with rare cancers or rare tumor changes. If you may qualify, it may help make these treatments more widely available in the future by studying how well they work and how patients feel.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This trial looks at your tumor (and blood) to find helpful targets so doctors can match you to an experimental targeted therapy, if one fits. It may help by using detailed “tumor profiling” to choose treatments more precisely for your cancer.
This trial builds a large database using your existing tumor genetic test results (DNA and/or RNA). It may help researchers better understand advanced cancers and use gene patterns to guide future care.
This program gathers tumor samples to study their genetic and immune (immune-system) features across many types of advanced cancer. Your information and tumor testing may help researchers understand which tumor features are present and how they relate to cancer behavior.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.